Nature

Evaluation of humoral immune response and milk antibody transfer in calves and lactating cows vaccinated with inactivated H5 avian influenza vaccine

The detection of Highly Pathogenic Avian Influenza (HPAI) A(H5N1) in dairy cattle in the United States has raised concerns about human exposure. This study evaluated the efficacy of various doses of ...
Infectious Disease Advisor

Additional RZV Dose Elicits Durable Immune Response in Older Adults

Adults aged 50 years and older demonstrate strong, durable immune responses after receiving an additional dose of the recombinant zoster vaccine.
Medical Xpress

Study demonstrates how cytokines produce long lasting humoral immunity following vaccination

A new study conducted by researchers from the German Rheumatology Research Center Berlin, an institute of the Leibniz Association, and the Charité—Universitätsmedizin Berlin has shed new light on how ...
Nature

Integrated analysis of humoral and memory B-cell responses reveals distinct immune landscapes shaped by influenza vaccine platforms

Influenza vaccination is central to reducing morbidity and mortality. However, vaccine-induced immune responses vary considerably across vaccine platforms. Hemagglutination inhibition (HAI) titers are ...
Frontiers

B cells, natural antibodies, and humoral rejection in kidney transplantation: innate immunity to donor-specific alloresponses

Antibody-mediated rejection (ABMR) remains the leading immunological cause of kidney allograft loss, yet its humoral origins are incompletely understood.
Monthly Prescribing Reference

Qivigy Approved for Primary Humoral Immunodeficiency in Adults

The product is expected to be available in early 2026. The Food and Drug Administration (FDA) has approved Qivigy (immune globulin intravenous [IV], human-kthm) 10% solution for the treatment of ...
Monthly Prescribing Reference

FDA Approves Yimmugo for Primary Humoral Immunodeficiency

The acute SBI rate was 0.07 during the 12-month study period, which met the predefined success rate of less than 1 acute SBI per patient per year. The Food and Drug Administration (FDA) has approved ...